Timothy R. Donahue

9.2k total citations
126 papers, 3.9k citations indexed

About

Timothy R. Donahue is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Timothy R. Donahue has authored 126 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Oncology, 66 papers in Surgery and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Timothy R. Donahue's work include Pancreatic and Hepatic Oncology Research (70 papers), Pancreatitis Pathology and Treatment (27 papers) and Neuroendocrine Tumor Research Advances (15 papers). Timothy R. Donahue is often cited by papers focused on Pancreatic and Hepatic Oncology Research (70 papers), Pancreatitis Pathology and Treatment (27 papers) and Neuroendocrine Tumor Research Advances (15 papers). Timothy R. Donahue collaborates with scholars based in United States, China and United Kingdom. Timothy R. Donahue's co-authors include O. Joe Hines, Howard A. Reber, David W. Dawson, Nanping Wu, Paul A. Toste, Hong Wu, Alexandra M. Moore, Alexander P. Stark, Brian E. Kadera and Reginald Hill and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Clinical Investigation.

In The Last Decade

Timothy R. Donahue

119 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy R. Donahue United States 37 2.2k 1.3k 1.1k 719 608 126 3.9k
Tetsuya Hamaguchi Japan 37 2.3k 1.0× 1.4k 1.0× 804 0.8× 423 0.6× 1.2k 1.9× 217 4.5k
Albrecht Neeße Germany 29 3.8k 1.7× 1.9k 1.4× 957 0.9× 1.3k 1.8× 607 1.0× 126 5.9k
Kyu‐pyo Kim South Korea 33 2.0k 0.9× 620 0.5× 1.6k 1.5× 452 0.6× 964 1.6× 197 3.8k
Jin Won Kim South Korea 36 2.2k 1.0× 1.1k 0.8× 1.3k 1.2× 396 0.6× 1.5k 2.4× 245 4.5k
Yan‐Shen Shan Taiwan 33 1.7k 0.8× 1.4k 1.1× 1.2k 1.1× 758 1.1× 890 1.5× 216 4.2k
Naomi Kiyota Japan 35 2.0k 0.9× 986 0.7× 1.1k 1.0× 379 0.5× 1.3k 2.1× 193 5.2k
Federica Tomao Italy 38 2.0k 0.9× 1.2k 0.9× 949 0.9× 731 1.0× 1.0k 1.7× 243 4.9k
Chigusa Morizane Japan 36 2.9k 1.3× 936 0.7× 1.6k 1.6× 828 1.2× 1.1k 1.8× 236 4.6k
Junji Kato Japan 38 967 0.4× 1.7k 1.3× 937 0.9× 416 0.6× 707 1.2× 197 5.5k
J Cassidy United Kingdom 33 1.7k 0.7× 1.2k 0.9× 482 0.5× 340 0.5× 594 1.0× 79 4.5k

Countries citing papers authored by Timothy R. Donahue

Since Specialization
Citations

This map shows the geographic impact of Timothy R. Donahue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy R. Donahue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy R. Donahue more than expected).

Fields of papers citing papers by Timothy R. Donahue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy R. Donahue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy R. Donahue. The network helps show where Timothy R. Donahue may publish in the future.

Co-authorship network of co-authors of Timothy R. Donahue

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy R. Donahue. A scholar is included among the top collaborators of Timothy R. Donahue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy R. Donahue. Timothy R. Donahue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Jamshidi, Neema, et al.. (2023). Construction of a radiogenomic association map of pancreatic ductal adenocarcinoma. BMC Cancer. 23(1). 189–189. 3 indexed citations
4.
Le, Thuc Duy, Khalid T. Rashid, Evan R. Abt, et al.. (2023). Generation of liver metastases in a mouse model using ultrasound-guided intravenous injection. STAR Protocols. 4(2). 102163–102163. 2 indexed citations
5.
Banerjee, Sudeep, Christopher P. Childers, Mark D. Girgis, et al.. (2023). Higher Numbers of Examined Lymph Nodes Are Associated with Increased Survival in Resected, Treatment-Naïve, Node-Positive Esophageal, Gastric, Pancreatic, and Colon Cancers. Journal of Gastrointestinal Surgery. 27(6). 1197–1207. 2 indexed citations
6.
O’Brien, Neil A., Martina S.J. McDermott, KeWei Gong, et al.. (2023). Development of a Novel CLDN18.2-directed Monoclonal Antibody and Antibody–Drug Conjugate for Treatment of CLDN18.2-Positive Cancers. Molecular Cancer Therapeutics. 22(12). 1365–1375. 5 indexed citations
7.
Aguilera, Kristina Y., Thuc Le, Rana Riahi, et al.. (2022). Porcupine Inhibition Disrupts Mitochondrial Function and Homeostasis in WNT Ligand–Addicted Pancreatic Cancer. Molecular Cancer Therapeutics. 21(6). 936–947. 7 indexed citations
8.
Maeda, Shimpei, Alexandra M. Moore, Lavanya Yohanathan, et al.. (2020). Impact of resection margin status on survival in pancreatic cancer patients after neoadjuvant treatment and pancreatoduodenectomy. Surgery. 167(5). 803–811. 33 indexed citations
9.
Elliott, Irmina A., Amanda M. Dann, Mark D. Girgis, et al.. (2019). Epidural Analgesia Improves Postoperative Pain Control but Impedes Early Discharge in Patients Undergoing Pancreatic Surgery. Pancreas. 48(5). 719–725. 16 indexed citations
10.
Toste, Paul A., Andrew H. Nguyen, Brian E. Kadera, et al.. (2016). Chemotherapy-Induced Inflammatory Gene Signature and Protumorigenic Phenotype in Pancreatic CAFs via Stress-Associated MAPK. Molecular Cancer Research. 14(5). 437–447. 55 indexed citations
11.
Huang, Wei, Ann E. Zeleniak, Antreas Hindoyan, et al.. (2016). Expression of GRP78, Master Regulator of the Unfolded Protein Response, Increases Chemoresistance in Pancreatic Ductal Adenocarcinoma. Molecular Cancer Therapeutics. 15(5). 1043–1052. 89 indexed citations
12.
Arensman, Michael D., Donatello Telesca, Kathleen M. Kershaw, et al.. (2014). The CREB-Binding Protein Inhibitor ICG-001 Suppresses Pancreatic Cancer Growth. Molecular Cancer Therapeutics. 13(10). 2303–2314. 89 indexed citations
13.
Kadera, Brian E., Paul A. Toste, Nanping Wu, et al.. (2014). Low Expression of the E3 Ubiquitin Ligase CBL Confers Chemoresistance in Human Pancreatic Cancer and Is Targeted by Epidermal Growth Factor Receptor Inhibition. Clinical Cancer Research. 21(1). 157–165. 22 indexed citations
14.
Donahue, Timothy R., Linh M. Tran, Reginald Hill, et al.. (2012). Integrative Survival-Based Molecular Profiling of Human Pancreatic Cancer. Clinical Cancer Research. 18(5). 1352–1363. 170 indexed citations
15.
Hill, Reginald, Yunfeng Li, Linh M. Tran, et al.. (2012). Cell Intrinsic Role of COX-2 in Pancreatic Cancer Development. Molecular Cancer Therapeutics. 11(10). 2127–2137. 75 indexed citations
16.
Donahue, Timothy R., Michael W. Kattan, Scott D. Nelson, et al.. (2010). Evaluation of neoadjuvant therapy and histopathologic response in primary, high‐grade retroperitoneal sarcomas using the sarcoma nomogram. Cancer. 116(16). 3883–3891. 46 indexed citations
17.
Hill, Reginald, Joseph Hargan Calvopina, Christine Kim, et al.. (2010). PTEN Loss Accelerates Kras G12D -Induced Pancreatic Cancer Development. Cancer Research. 70(18). 7114–7124. 132 indexed citations
18.
Donahue, Timothy R., O. Joe Hines, James J. Farrell, et al.. (2010). Cystic Neoplasms of the Pancreas. Pancreas. 39(8). 1271–1276. 20 indexed citations
19.
Vo, Dan D., Robert M. Prins, Jonathan L. Begley, et al.. (2009). Enhanced Antitumor Activity Induced by Adoptive T-Cell Transfer and Adjunctive Use of the Histone Deacetylase Inhibitor LAQ824. Cancer Research. 69(22). 8693–8699. 119 indexed citations
20.
Ribas, Antoni, Begoña Comı́n-Anduix, James S. Economou, et al.. (2008). Intratumoral Immune Cell Infiltrates, FoxP3, and Indoleamine 2,3-Dioxygenase in Patients with Melanoma Undergoing CTLA4 Blockade. Clinical Cancer Research. 15(1). 390–399. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tetsuya Hamaguchi Breakdown of academic impact, for papers by Albrecht Neeße Breakdown of academic impact, for papers by Kyu‐pyo Kim Breakdown of academic impact, for papers by Jin Won Kim Breakdown of academic impact, for papers by Yan‐Shen Shan Breakdown of academic impact, for papers by Naomi Kiyota Breakdown of academic impact, for papers by Federica Tomao Breakdown of academic impact, for papers by Chigusa Morizane Breakdown of academic impact, for papers by Junji Kato Breakdown of academic impact, for papers by J Cassidy
Rankless by CCL
2026